BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 26530403)

  • 1. Association between HER2 status in gastric cancer and clinicopathological features: a retrospective study using whole-tissue sections.
    Laboissiere RS; Buzelin MA; Balabram D; De Brot M; Nunes CB; Rocha RM; Cabral MM; Gobbi H
    BMC Gastroenterol; 2015 Nov; 15():157. PubMed ID: 26530403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
    He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
    World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HER2 in gastric cancer: comparative analysis of three different antibodies using whole-tissue sections and tissue microarrays.
    Abrahão-Machado LF; Jácome AA; Wohnrath DR; dos Santos JS; Carneseca EC; Fregnani JH; Scapulatempo-Neto C
    World J Gastroenterol; 2013 Oct; 19(38):6438-46. PubMed ID: 24151362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between HER2 expression and tumor interstitial angiogenesis in primary gastric cancer and its effect on prognosis.
    Li F; Meng G; Tan B; Chen Z; Ji Q; Wang X; Liu C; Niu S; Li Y; Liu Y
    Pathol Res Pract; 2021 Jan; 217():153280. PubMed ID: 33253925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immuno-Histochemical Assessment of HER2NEU Expression in Gastric Adenocarcinoma in North Karnataka, India.
    Nadaf AS; Rani H; Dinesh US
    Asian Pac J Cancer Prev; 2018 May; 19(5):1381-1385. PubMed ID: 29802704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HER2 expression and its clinicopathological features in resectable gastric cancer.
    Kataoka Y; Okabe H; Yoshizawa A; Minamiguchi S; Yoshimura K; Haga H; Sakai Y
    Gastric Cancer; 2013 Jan; 16(1):84-93. PubMed ID: 22410801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER2 expression and relevant clinicopathological features in gastric and gastroesophageal junction adenocarcinoma in a Chinese population.
    Shan L; Ying J; Lu N
    Diagn Pathol; 2013 May; 8():76. PubMed ID: 23656792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human epidermal growth factor receptor 2 expression in mixed gastric carcinoma.
    Wang YK; Chen Z; Yun T; Li CY; Jiang B; Lv XX; Chu GH; Wang SN; Yan H; Shi LF
    World J Gastroenterol; 2015 Apr; 21(15):4680-7. PubMed ID: 25914479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of HER2 Positivity and Its Clinicopathological Correlation in Locally Advanced/Metastatic Gastric Cancer Patients in Malaysia.
    Rajadurai P; Fatt HK; Ching FY
    J Gastrointest Cancer; 2018 Jun; 49(2):150-157. PubMed ID: 28124769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HER2 in gastric cancer: a digital image analysis in pre-neoplastic, primary and metastatic lesions.
    Fusco N; Rocco EG; Del Conte C; Pellegrini C; Bulfamante G; Di Nuovo F; Romagnoli S; Bosari S
    Mod Pathol; 2013 Jun; 26(6):816-24. PubMed ID: 23348899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HER2 expression in gastric and gastroesophageal junction adenocarcinoma in a US population: clinicopathologic analysis with proposed approach to HER2 assessment.
    Kunz PL; Mojtahed A; Fisher GA; Ford JM; Chang DT; Balise RR; Bangs CD; Cherry AM; Pai RK
    Appl Immunohistochem Mol Morphol; 2012 Jan; 20(1):13-24. PubMed ID: 21617522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between HSP90 and Her2 in gastric and gastroesophageal carcinomas.
    Berezowska S; Novotny A; Bauer K; Feuchtinger A; Slotta-Huspenina J; Becker K; Langer R; Walch A
    PLoS One; 2013; 8(7):e69098. PubMed ID: 23874879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discordances in HER2 status between primary gastric cancer and corresponding metastatic sites.
    Gumusay O; Benekli M; Ekinci O; Baykara M; Ozet A; Coskun U; Demirci U; Uner A; Dursun A; Atak EY; Buyukberber S
    Jpn J Clin Oncol; 2015 May; 45(5):416-21. PubMed ID: 25732909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of HER2 status in primary and paired metastatic sites of gastric carcinoma.
    Bozzetti C; Negri FV; Lagrasta CA; Crafa P; Bassano C; Tamagnini I; Gardini G; Nizzoli R; Leonardi F; Gasparro D; Camisa R; Cavalli S; Silini EM; Ardizzoni A
    Br J Cancer; 2011 Apr; 104(9):1372-6. PubMed ID: 21487407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations between Her2 oncoprotein, VEGF expression, MVD and clinicopathological parameters in gastric cancer.
    Bădescu A; Georgescu CV; Vere CC; Crăiţoiu S; Grigore D
    Rom J Morphol Embryol; 2012; 53(4):997-1005. PubMed ID: 23303024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of HER2 protein expression in gastric carcinomas: comparative analysis of 1,414 cases of whole-tissue sections and 595 cases of tissue microarrays.
    Kim KC; Koh YW; Chang HM; Kim TH; Yook JH; Kim BS; Jang SJ; Park YS
    Ann Surg Oncol; 2011 Oct; 18(10):2833-40. PubMed ID: 21468783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of intratumoral heterogeneity of HER2 expression between primary tumor and multiple organ metastases in gastric cancer: Clinicopathological study of three autopsy cases and one resected case.
    Saito T; Kondo C; Shitara K; Ito Y; Saito N; Ikehara Y; Yatabe Y; Yamamichi K; Tanaka H; Nakanishi H
    Pathol Int; 2015 Jun; 65(6):309-17. PubMed ID: 25828363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological factors associated with HER2-positive gastric cancer: A meta-analysis.
    Wang HB; Liao XF; Zhang J
    Medicine (Baltimore); 2017 Nov; 96(44):e8437. PubMed ID: 29095284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HER2 is frequently overexpressed in hepatoid adenocarcinoma and gastric carcinoma with enteroblastic differentiation: a comparison of 35 cases to 334 gastric carcinomas of other histological types.
    Fujimoto M; Matsuzaki I; Nishino M; Iwahashi Y; Warigaya K; Kojima F; Ono K; Murata SI
    J Clin Pathol; 2018 Jul; 71(7):600-607. PubMed ID: 29305518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of HER2 status between surgically resected specimens and matched biopsy specimens of gastric intestinal-type adenocarcinoma.
    Yoshida H; Yamamoto N; Taniguchi H; Oda I; Katai H; Kushima R; Tsuda H
    Virchows Arch; 2014 Aug; 465(2):145-54. PubMed ID: 24889042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.